Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.20 $16.47 Friday, 10th May 2024 VRDN stock ended at $13.90. This is 0.0719% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.32% from a day low at $13.34 to a day high of $14.05.
90 days $12.20 $21.42
52 weeks $10.93 $28.35

Historical Viridian Therapeutics, Inc. prices

Date Open High Low Close Volume
Dec 15, 2023 $19.38 $19.68 $18.75 $19.22 1 624 674
Dec 14, 2023 $20.00 $20.00 $18.75 $19.34 1 781 392
Dec 13, 2023 $17.16 $19.27 $17.16 $19.23 921 169
Dec 12, 2023 $16.64 $17.35 $16.41 $17.18 929 619
Dec 11, 2023 $18.20 $18.23 $16.77 $16.90 728 751
Dec 08, 2023 $18.58 $18.81 $18.12 $18.14 493 673
Dec 07, 2023 $17.78 $18.98 $17.78 $18.59 816 301
Dec 06, 2023 $17.90 $18.12 $17.44 $17.76 633 590
Dec 05, 2023 $17.86 $17.96 $17.44 $17.55 482 441
Dec 04, 2023 $17.28 $18.34 $17.10 $17.88 723 662
Dec 01, 2023 $16.70 $17.34 $16.39 $17.22 477 076
Nov 30, 2023 $16.78 $17.61 $16.41 $16.74 964 796
Nov 29, 2023 $15.78 $17.15 $15.78 $16.48 685 005
Nov 28, 2023 $16.01 $16.20 $15.33 $15.66 524 230
Nov 27, 2023 $15.79 $16.29 $15.04 $15.91 1 498 835
Nov 24, 2023 $15.73 $16.31 $15.73 $16.31 151 028
Nov 22, 2023 $16.06 $16.07 $15.65 $15.68 476 880
Nov 21, 2023 $16.08 $16.61 $15.70 $15.70 545 857
Nov 20, 2023 $15.78 $16.62 $15.51 $16.19 633 235
Nov 17, 2023 $15.37 $16.00 $15.12 $15.88 517 609
Nov 16, 2023 $15.85 $15.85 $14.85 $15.20 828 760
Nov 15, 2023 $15.00 $16.90 $14.30 $15.98 870 584
Nov 14, 2023 $14.72 $15.49 $14.52 $15.22 1 407 841
Nov 13, 2023 $13.78 $14.00 $13.38 $13.99 447 052
Nov 10, 2023 $13.74 $13.86 $13.00 $13.76 518 190
Click to get the best stock tips daily for free!

About Viridian Therapeutics, Inc.

Viridian Therapeutics. Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as ... VRDN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT